OTC Vitamins & Dietary Supplements Market Production, Consumption, Revenue and Market share Details

Over-the-counter (OTC) vitamins and dietary supplements are sold directly to consumers without any medical prescription. In many countries, OTC vitamins and dietary supplement products are regulated to ensure that they are effective and safe when used. Drug regulatory bodies allow manufacturers to formulate vitamin ingredients or combination of ingredients that are well tolerated and do not pose any risk of side effects or reactions.

Request For Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=61

Following insights from Fact.MR’s report on the global market for OTC vitamins and dietary supplements will be crucial for market’s future growth

1) Among regions, North America is expected to remain one of the most lucrative market for OTC vitamins and dietary supplements between 2017 and 2022. The region currently commands for the highest value share of the global market as demand for various OTC drugs is on the rise particularly in the U.S. Asia Pacific excluding Japan (APEJ) is also projected to emerge as an attractive market for OTC vitamins and dietary supplements over 2022. In terms of revenue, the market in Europe is anticipated to command for over 31% share of the global market, by 2017-end.
2) On the basis of functions, OTC vitamins and dietary supplements are being used majorly for maintaining general well-being of the body. The general well-being segment accounts for a large percentage of the overall market revenue.
3) In 2017 and beyond, pharmacies will continue to be the top OCT channel for sales of OTC vitamin products including capsules and tablets. Over one-fourth revenue share of the global market is currently captured by the pharmacy OTC channel segment. Though, this OTC channel segment is expected to lose a small fraction of its revenue share over 2020, mainly due to emergence of new OCT channels such online retail and modern trade.
4) Sales of capsule based OTC vitamins and dietary supplements will continue to remain strong during the forecast period. By 2022-end, nearly US$ 32,891 Mn worth capsules are estimated to be sold across the globe.

North America’s Leadership in Global OTC Vitamins and Dietary Supplement Market to Remain Unchallenged
The market for OTC vitamins and dietary supplements in North America is expected to remain highly lucrative during the forecast period. Currently, the region accounts for the largest share of the global market in terms of value. This is primarily owing to soaring demand for OTC drugs particularly in the U.S. Meanwhile, the market in Asia Pacific excluding Japan (APEJ) is also expected to witness an impressive growth over the forecast period (2017-2022). By 2017-end, Europe is estimated to account for more than 31% revenue share of the global market.

By function, use of OTC vitamins and dietary supplements will be robust for the general well-being of the body. Throughout the forecast period, global revenue from sales of OTC vitamins and dietary supplements for general well-being will continue to exhibit strong growth.

Pharmacies will remain the leading OCT channel for OTC vitamins and dietary supplements in 2017 and beyond. Pharmacies currently account for more than one-fourth share of the global market in terms of revenue. However, this OTC channel segment of the market is expected to lose 141 BPS toward the end of the forecast period.

Based on product form, global sales of OTC vitamin and dietary supplements capsules are expected to remain relatively higher over 2022. Close to US$ 33 Bn worth of capsules are expected to be consumed worldwide by the end of the forecast period.

Browse Full Report with TOC @ https://www.factmr.com/report/61/otc-vitamins-dietary-supplements-market

Competition Tracking
The global OTC vitamins and dietary supplements market remains highly competitive with several leading companies partaking in it, which include BASF SE, DuPont, Koninklijke DSM N.V., Archer Daniels Midland Company., Lonza Group Ltd, Jubilant Life Sciences Limited, Atrium Innovations, Inc., Sanofi S.A., Pfizer, Inc., GlaxoSmithKline plc, Dil Limited., Reckitt Benckiser LLC, CSPC Pharmaceutical Group Limited., Otsuka Holdings Co. Ltd., and Bactolac Pharmaceutical, Inc.

Check Discount @ https://www.factmr.com/connectus/sample?flag=D&rep_id=61

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

This release was published on openPR.